Micu D, Gociu M, Zamfirescu-gheorghiu M, Mihăilescu E, Cheţa D, Cheţa N, Astaldi A
Med Interne. 1975;13(3):199-203.
Over 20 cytoenzymochemical tests were carried out in 152 patients with different types of acute leukemia to estimate the effects of some antiblastic drugs such as L-asparaginase, Purinethol, Methotrexate, Endoxan, Vinchristine, Cytosine Arabinoside a.o. The patients selected for the study were carefully examined before treatment at different moments during and/or at the end of the treatment. The effects of these drugs on the blast cells were mild when the cellular populations had a low rate of nucleic acid synthesis, high glycogenic score and high amounts of lipids or an important oxidative enzymatic activity. The enzymatic prediction tests: the acid phosphate deviation test and the succinic dehydrogenase inhibition test including the variant suggested by some of the authors - the latic dehydrogenase inhibition test - gave satisfactory results only in certain cases of acute leukemia.
对152例不同类型急性白血病患者进行了20多项细胞酶化学检测,以评估某些抗白血病药物的效果,如L-天冬酰胺酶、巯嘌呤、甲氨蝶呤、环磷酰胺、长春新碱、阿糖胞苷等。入选该研究的患者在治疗前、治疗期间不同时刻和/或治疗结束时均经过仔细检查。当细胞群体核酸合成率低、糖原评分高、脂质含量高或具有重要的氧化酶活性时,这些药物对原始细胞的作用较轻。酶预测试验:酸性磷酸酶偏差试验和琥珀酸脱氢酶抑制试验,包括一些作者提出的变体——乳酸脱氢酶抑制试验,仅在某些急性白血病病例中取得了满意的结果。